Dr Jeffery J. Auletta, from NMDP/Be The Match, reviews data on mismatched unrelated donor transplants in a diverse population of patients with hematologic malignancies.
Interviews with survivors of allogeneic hemotopoietic stem cell transplantation revealed their experiences with cognitive difficulties after treatment.
This retrospective, observational study sought to determine the effect of time to postdischarge follow-up on ED visits and readmission in patients with cancer transitioning to outpatient care.
Researchers sought to determine scanning techniques in antimicrobial management for high-risk patients who have persistent or recurrent neutropenic fever.
Researchers sought to determine whether using convalescent plasma or plasma from vaccinated donors could improve COVID-19 in patients with a hematologic malignancy or immunosuppression.
Researchers sought to determine whether GVHD prophylaxis after allo-HSCT with posttransplant cyclophosphamide plus a short course of cyclosporine A would improve outcomes.
Patients trust that what they tell their doctors will remain confidential, but under certain specific circumstances, the doctors may be obligated to breach that trust.
Researchers sought to determine whether long-term ropeginterferon alfa-2b would have benefits in patients with PV compared with hydroxyurea or the best available treatment.
Researchers sought to find whether there was a relationship between patient-reported outcomes and overall survival after hematopoietic stem cell transplantation.
Researchers sought to determine whether varicella-zoster virus vaccination with a recombinant vaccine would show results in patients who underwent HSCT.
The approval was based on data demonstrating a high degree of similarity of Fylnetra to the reference product, with no clinically meaningful differences.
The final 6 months of life is presumed to be a high-risk period for depression and anxiety in patients with cancer. However, few studies have examined whether depression and anxiety do occur in the last year of life and to what extent.
A study sought to determine the impact of infection, gastrointestinal, bone/muscle, and metabolic/endocrine complications in patients receiving steroids for GVHD on HCRU and costs.
Researchers assessed the characteristics and distribution of hepatitis C virus (HCV) genotypes among individuals with confirmed HCV infection who donated blood during a 16-year period.
Having a high blood tumor mutational burden was associated with a significant improvement in response and a trend toward improvement in survival outcomes.
